CC Chemours Co

8-K Current Report

Filed: February 26, 2026

Health Care

Chemicals & Allied Products

Chemours Co (CC) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• $700M senior unsecured notes at 7.875% due 2034, priced in private offering exempt from Securities Act registration
• Deal upsized by $100M from initial $600M target — strong investor demand signal

+2 more insights

Other Chemours Co 8-K Filings

8-K Mar 12, 2026

Get deeper insights on Chemours Co

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.